Ofatumumab trials for Multiple sclerosis

All Ofatumumab trials · All Multiple sclerosis trials

Phase breakdown

Recruiting trials studying Ofatumumab for Multiple sclerosis

• A NIS Evaluating Various Injectable and Oral Treatments in Patients With Relapsing Multiple Sclerosis
  NCT05344469 · Phase: Not specified · Ages: 18 Years to 100 Years · Sex: All (male and female) · 141 locations
• Exploring the Efficacy and Safety of Ofatumumab in Patients With Relapsing Multiple Sclerosis (RMS) and Its Impact on Serum Neurofilament Light Chain (sNfL) Levels
  NCT07353216 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Kesimpta (Ofatumumab) in Greek Multiple Sclerosis Patients - an Observational Study
  NCT06486779 · Phase: Not specified · Ages: 18 Years to 55 Years · Sex: All (male and female) · 15 locations
• Ofatumumab in Portuguese Multiple Sclerosis Patients - an Observational Study
  NCT05809986 · Phase: Not specified · Ages: 18 Years to 99 Years · Sex: All (male and female) · 10 locations

Common questions

How many trials study Ofatumumab for Multiple sclerosis?

4 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.